Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruyi Zhenbao Tablets and Baimai Ointment for acute ischemic stroke
ChiCTR2000036691Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ruyizhenbao pill and Baimai in ischemic stroke (4 arms), sponsored by Xuanwu Hospital. Primary endpoint: Day 90 change from baseline in simplified Fugl-Meyer score. Started Sep 2020; status: completed.
02
Drugs
ruyizhenbao pillBaimai
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000036691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036691.